Digital Genome Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

December 9, 2020 Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular Cartography TM platform    MONHEIM AM RHEIN, Germany – Dec. 10, 2020 – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer.   The company s Molecular Cartography platform is a groundbreaking multi-analyte and highly multiplex spatial analysis technology that enables scientists to resolve the most daunting biological challenges in areas such as oncology, neuroscience, and infectious disease. It produces deep contextual data sets that illuminate molecular interactions at subcellular resolution, while preserving the sample tissue. The initial applications of Resolve s Molecular Cartography platform deliver the highest-resolution view of

John shoffnerJasont gammackPeerm schatzMastermind advisory servicesPromega corporationResolve biosciencesMolecular cartographyCo founder jasonChief executiveAlafi capitalChief commercial officerDigital genome engineeringVice presidentLife science businessIngenuity systemsLife technologies